They are not intended to replace or mimic GLP-1 medications
Because GLP-1 medications slow digestion, some people can experience constipation
Alrededor del ao 1920 se introdujo el trmino incretina que fue el primero en ser usado para definir los factores que regulan la secrecin del pncreas, no obstante, la conexin entre el tracto gastrointestinal y el pncreas solo se propus a finales de la dcada de 1960 cuando la insulina se empez a medir en el plasma
Raoul Manalac, GLP-1 drugs can be some of the most effective tools we have to support weight loss
But GLP-1 meds often reduce appetite and thirst , which means many patients end up dehydrated
While gastrointestinal AEs such as nausea and vomiting dominate safety reports 8 and recent pharmacovigilance studies highlight increasingly recognized risks including acute pancreatitis, nephritis, hypotension, and syncope 9,10,11 , emerging data suggest that GLP-1 RAs may be associated with neurological adverse events (NAEs) 12,13